Clinical Trial Update: Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390 [Phase 3]

View source ↗

Summary

Phase 3 results were posted for a trial in Hepatitis C patients who were non-responders and had previously participated in eltrombopag studies (TPL 103922 or TP…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2013-12-06